ArticleJournal for immunotherapy of cancer2024

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.

Vicky Makker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.